Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency for SBS and MVID. In October 2025, as announced, the company ...

This comprehensive review synthesizes a decade of human and animal research to explain how the gut and brain communicate ...

Every night, millions of people work hard to keep our essential services running—treating patients, responding to emergencies ...

Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...

Intestinal stem cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for ...

Chronic Intestinal Pseudo-Obstruction (CIPO) and related gastrointestinal motility disorders constitute a group of rare but debilitating conditions that mimic mechanical obstruction despite the ...

Learn why the gut–brain connection increases stress and affects IBS symptoms and explore evidence-based treatments like ...

A decrease in protein synthesis in cells of the developing gut contributes to a rare genetic disorder, and an inexpensive nutritional supplement may help reverse that decrease, according to a new ...

With digestive disorders emerging as one of the most common yet under-addressed health concerns in India, Kauvery Hospital, ...